Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
96
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Uncontrolled hyperlipidemia in Chinese patients who experienced acute coronary syndrome: an observational study

Jie Jiang1 Department of Cardiology, Peking University First Hospital, Xicheng District, Beijing 100034, China, [email protected]
,
Yu-Jie Zhou2 Department of Cardiology, Beijing Anzhen Hospital, Chaoyang District, Beijing 100029, China
,
Jian-Jun Li3 Department of Cardiology, Fuwai Hospital, Xicheng District, Beijing 100037, China
,
Jun-Bo Ge4 Department of Cardiology, Fudan University Zhongshan Hospital, Xuhui District, Shanghai 200032, China
,
Ying-Qing Feng5 Department of Cardiology, Guangdong General Hospital, Yuexiu District, Guangzhou, Guangdong Province 510080, China
,
Yong Huo1 Department of Cardiology, Peking University First Hospital, Xicheng District, Beijing 100034, China, [email protected]Correspondence[email protected]
& On behalf of ASAP Study Investigators show all
Pages 2255-2264 | Published online: 16 Nov 2018

References

  • WangWTHellkampADollJALipid testing and statin dosing after acute myocardial infarctionJ Am Heart Assoc201873e00646029371200
  • EisenACannonCPBraunwaldEPredictors of nonuse of a high-potency statin after an acute coronary syndrome: insights from the stabilization of plaques using darapladib-thrombolysis in myocardial infarction 52 (SOLID-TIMI 52) trialJ Am Heart Assoc201761e00433228077384
  • SchieleFFarnierMKrempfMBruckertEFerrièresJFrench GroupA consensus statement on lipid management after acute coronary syndromeEur Heart J Acute Cardiovasc Care20187653254327856518
  • FerenceBAGinsbergHNGrahamILow-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the european atherosclerosis society consensus panelEur Heart J201738322459247228444290
  • SampsonUKFazioSLintonMFResidual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challengesCurr Atheroscler Rep201214111022102062
  • ZhangWJiFYuXWangXFactors associated with unattained LDL-cholesterol goals in Chinese patients with acute coronary syndrome one year after percutaneous coronary interventionMedicine (Baltimore)2017961e546928072688
  • ZhaoSWangYMuYDYSIS-China Study InvestigatorsPrevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS)Atherosclerosis2014235246346924950001
  • Joint committee issued Chinese guideline for the management of dyslipidemia in adults2016 Chinese guideline for the management of dyslipidemia in adultsZhonghua Xin Xue Guan Bing Za Zhi2016441083385327903370
  • ZhengWZhangY-JBuX-TLDL-cholesterol goal attainment under persistent lipid-lowering therapy in northeast ChinaMedicine (Baltimore)20179646e855529145263
  • Perez de IslaLAlonsoRWattsGFSAFEHEART InvestigatorsAttainment of LDL-Cholesterol treatment goals in patients with familial hypercholesterolemia: 5-Year SAFEHEART registry follow-UpJ Am Coll Cardiol201667111278128526988947
  • GittAKLautschDFerrièresJCholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study IIAtherosclerosis201726615816629028484
  • JoseJStatins and its hepatic effects: Newer data, implications, and changing recommendationsJ Pharm Bioallied Sci201681232826957864
  • ArcaMPignaGTreating statin-intolerant patientsDiabetes Metab Syndr Obes2011415516621779147

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.